Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T.

MLA

LaHucik, Kyle. “Arcellx Raises $124M in Wall Street Debut to Bankroll Study of Multiple Myeloma CAR-T.” FierceBiotech, Feb. 2022, p. N.PAG. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=155108955&authtype=sso&custid=ns315887.

APA

LaHucik, K. (2022). Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T. FierceBiotech, N.PAG.

Chicago

LaHucik, Kyle. 2022. “Arcellx Raises $124M in Wall Street Debut to Bankroll Study of Multiple Myeloma CAR-T.” FierceBiotech, February, N.PAG. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=155108955&authtype=sso&custid=ns315887.